LOINCActiveBoth

LOINC Code 81643-9: vWf ristocetin cofactor act/vWf Ag (PPP) [Ratio]

81643-9 is a LOINC code used to identify vWf ristocetin cofactor act/vWf Ag (PPP) [Ratio] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component von Willebrand factor.ristocetin cofactor activity/von Willebrand factor Ag. It is commonly used with the system or sample type PPP.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component von Willebrand factor.ristocetin cofactor activity/von Willebrand factor Ag. It is commonly used with the system or sample type PPP.

When is it used?

  • Used in lab systems, EHRs, and clinical data exchange.
  • May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
  • Status: ACTIVE
  • Order vs observation: Both

What it does not mean

  • The code identifies the observation or test, not the actual result.

Key facts

von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasma
von Willebrand factor.ristocetin cofactor activity/von Willebrand factor Ag
This term represents a ratio of two results that are expressed as percentages of normalthe von Willebrand factor.ristocetin cofactor activity and the von Willebrand factor antigen concentration, both of which are reported as actual/Normal. The von Willebrand factor (vWF) ristocetin cofactor activity to antigen ratio can help distinguish different types of von Willebrand disease (VWD). VWD types 1 and 3 are usually associated with a quantitative decrease in vWF, which would affect both the vWF ristocetin cofactor activity as well as vWF antigen concentration, while type 2 is associated with a functional defect in VWF, which would affect the activity but not the amount of antigen present. Therefore, patients with type 2 VWD are likely to have a lower vWF ristocetin cofactor activity to antigen ratio (less than 0.6-0.7) compared to patients with types 1 or 3 VWD.
Activ; Actvty; AggRecetin; COAGULATION; Cofact; Fac; Fact; Hematology; Heme; Movements; Plas; Platelet poor plasma; Point in time; QNT; Quan; Quant; Quantitative; Random; Ratios; Risto; Rto; Von will; Von willebrand factor activity; Vonwillebrand; vWf; vWf Activity; vWFAg; vWf:RCo

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

vWf ristocetin cofactor act/vWf Ag (PPP) [Ratio]von Willebrand factor (vWf) ristocetin cofactor/von Willebrand factor (vWf) Ag [Ratio] in Platelet poor plasmavWf:RCo/vWF Ag PPP-Rtovon Willebrand factor.ristocetin cofactor activity/von Willebrand factor AgCOAGvWf Ristocetin Cofactor Activity/Antigen, BloodRatio

Frequently asked questions

Code details

Code81643-9
SystemLOINC
Display namevWf ristocetin cofactor act/vWf Ag (PPP) [Ratio]
Descriptionvon Willebrand factor.ristocetin cofactor activity/von Willebrand factor Ag
Short namevWf:RCo/vWF Ag PPP-Rto
Componentvon Willebrand factor.ristocetin cofactor activity/von Willebrand factor Ag
PropertyRatio
TimingPt
System (specimen)PPP
ScaleQn
ClassCOAG
Example unitsratio
StatusACTIVE
Order/ObservationBoth

Flags

BillableNo
Valid clinical useNo

Source

SourceLOINC
Version2.82
Releasemain
First released2.56
Last changed2.73

Consumer names

vWf Ristocetin Cofactor Activity/Antigen, Blood

Part names

von Willebrand factor.ristocetin cofactor activity/von Willebrand factor AgRatioPtPPPQnPoint in time (spot)Platelet poor plasma

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.